Diabetes drug that may slow Parkinson's - Cure Parkinson's

Cure Parkinson's

25,550 members26,870 posts

Diabetes drug that may slow Parkinson's

Court profile image
8 Replies

This article was featured in today's paper. It says that a drug used in the treatment of Type 2 diabetes is being tried on early stage Parkinson's patients. It appears that research has shown that it appears to slow down the loss of brain cells that produce dopamine. This drug also affects levels of immune cells in the brain, which may protect against inflammation and oxidisation damage, both implicated in Parkinsons.

As this drug is already in use, if the trials prove positive, let's hope it is available to Parkinsons patients before too long.

Sue :-)

Written by
Court profile image
Court
To view profiles and participate in discussions please or .
Read more about...
8 Replies

Sounds exciting!

Praying it does work and trials prove positive for us!

Moderator_1 profile image
Moderator_1

Regarding this medication posters may be interested in the following:

Information from the CPT site. CPT are the parent organisation of Parkinsons Movement.

CURRENT RESEARCH BEING FUNDED BY THE CURE PARKINSON'S TRUST

Exendin

Dr Tom Foltynie

University College London

Exendin is an existing treatment for Diabetes type 2 which appears to have both a neuroprotective and restorative effect. This is being investigated in 20 patients who have been recruited to take part in a pilot study which we have co-designed and are now funding. The trial is being conducted at University College London by Dr Tom Foltynie.

Also an report on Parkinsons Movement main site,

parkinsonsmovement.com/2011...

Court profile image
Court in reply to Moderator_1

Thank you for this information. I was not sure whether it was alright to share this information, but as it was in the paper I thought it was, hopefully, a positive thing, and wanted to share it.

Jeni profile image
Jeni

I appreciate any and all information....thanks....

hilarypeta profile image
hilarypeta in reply to Jeni

ThanksFor info.. I was told i was borderline diabetic after glucose tolerance test but always have low blood sugar in normal blood tests...always wonder why?

jeaniegal profile image
jeaniegal

I am in the study for the drug I think you are talking about, pioglitazone. It is a drug that is already approved to treat diabetes. I've been taking the drug since February and what I notice is a reduction in the slowness of my body movements, I can smell things much better, and I have no side effects from the medication. Other than that, I struggle along with my same old symptoms but they do not appear to be getting any worse, which of course, is my main concern.. The only other medication I take is Azilect, which is all you can take to be in the study. I drive an hour and a half each way to the study site and get paid $20 which does not even cover the gas, but of course it is not about the money, it is about helping. Helping myself as well as others.

Court profile image
Court

This is very interesting though perhaps not as many positive results as I was hoping for.

Am not sure if this is the same drug the paper was referring to, but it seems too much of a coincidence for there to be two similar drugs

wifeofparky profile image
wifeofparky

It is known as Actos in the US and has been linked to bladder cancer. If you have any urinary issues, I'd discuss this closely with your Primary doctor before discussing with your neuro.

You may also like...

Parkinson's disease drug ropinirole safely slows the progression of amyotrophic lateral sclerosis

be/1iX7bTGtW_8...

Ginkgo Biloba And Drug Induced Parkinsonism

looking at the following study which used GB in drug induced parkinsonism (DIP) at a dose of...

Help in understanding drugs in Parkinsons

I've recently been diagnosed with Parkinsons and have been prescribed LevaDopa -1/2 tablet (125mg) 4

Reducing oxidative stress and inflammation to slow Parkinson's disease

age. It is particularly strong in dopamine cells where it damages cell membranes and mitochondria....

Parkinson's Drug Reduces Disease Markers in Breakthrough Trial

https://www.sciencealert.com/parkinsons-drug-reduces-disease-markers-in-breakthrough-trial